top of page
Picture3.png

Academic publications

Research articles

¹Co-first authors
²corresponding authors

  1. Kabir T¹, Anwar S¹, Taslem Mourosi J, Akter S, Hosen MJ. α-and β-globin gene mutations in individuals with hemoglobinopathies in the Chattogram and Sylhet regions of Bangladesh. Hemoglobin. 2023 Mar 8; 47(1): 3–10.

  2. Shaheen N, Azam A, Ganguly A, Anwar S, et al. Anti-inflammatory and analgesic activities of black cumin (BC, Nigella sativa L.) extracts in in vivo model systems. Bull Natl Res Cent. 2022 Nov 2; 46: 26 (1–8).

  3. Toma NJ¹, Anwar S¹, Kabir T, Hosen MJ. Lead and lead-arsenic combined exposure induces mortality and developmental impairments in zebrafish embryos: a study using wild-caught zebrafish from Bangladesh. Drug Chem Toxicol. 2022 Nov 7; 45(6): 2833–2842.

  4. Laura FK, Miah MF, Chowdhury SF, Anwar S, Reshad RA, Mahmud MG, Faruque CM. Inheritance of β hemoglobin gene mutation: potential method of newborn screening of sickle cell anemia in Bangladesh. J Clin Trials Exp Investig. 2022 Jun 1; 13(2): em00795.

  5. Chiba S, Lim KR, Sheri N, Anwar S, et al. eSkip-Finder: a machine learning-based web application and database to identify the optimal sequences of antisense oligonucleotides for exon skipping. Nucleic Acid Res. 2021 Jul 2; 49(W1): W193-8.

  6. Parvez MS, Rahman MM, Morshed MN, Rahman D, Anwar S, Hosen MJ. Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: Insights into the origin, mutational spectrum and possible pathomechanism. Comput Biol Chem. 2021 Feb 1; 90: 107413.

  7. Anwar S, He M, Lim KRQ, Maruyama R, Yokota T. A genotype-phenotype correlation study of exon skip-equivalent in-frame deletions and exon skip-amenable out-of-frame deletions across the DMD gene to simulate the effects of exon-skipping therapies: a meta-analysis. J Pers Med. 2021 Jan 14; 11(1): 46.

  8. Anwar S, Taslem Mourosi J, Arafat Y, Hosen MJ. Genetic and reproductive consequences of consanguineous marriage in Bangladesh. PLOS One. 2020 Nov 30; 15(11): e0241610.

  9. Anwar S, Araf Y, Newaz Khan A, Ullah MA, Hoque N, Sarkar B. Women’s knowledge, attitude, and perceptions toward COVID-19 in lower-middle-income countries: a representative cross-sectional study in Bangladesh. Front Public Health. 2020 Nov 17; 8: 571689.

  10. Islam R, Parvez MS, Anwar S, Hosen MJ. Delineating blueprint of an epitope-based peptide vaccine against the multiple serovars of dengue virus: a hierarchical reverse vaccinology approach. Inform Med Unlocked. 2020 Sep 15; 20 (100430).

  11. Ali MH, Anwar S, Toma NJ, Rafid I, Hasan MK, Foysal MJ. Molecular detection and PCR-RFLP analysis of mucoviscosity-associated gene A (magA) in clinical isolates of multidrug-resistant Klebsiella pneumoniae in Bangladesh. Open Microbiol J. 2020 Sep 5; 14(1): 196–204.

  12. Anwar S, Taslem Mourosi J, Hasan MK, Hosen MJ, Miah MF. Umbilical cord blood screening for the detection of common deletional mutations of α-thalassemia in Bangladesh. Hemoglobin. 2020 Jul 01; 44(3): 201–210.

  13. Anwar S, Taslem Mourosi J, Khan MF, Hosen MJ. Prediction of epitope-based peptide vaccine against the chikungunya virus by immuno-informatics approach. Curr Pharm Biotechnol. 2020 Mar 1; 21(4): 325–40.

  14. Anwar S, Taslem Mourosi J, Khan MF, Ullah MO, Vanakker OM, Hosen MJ. Chikungunya outbreak in Bangladesh (2017): clinical and hematological findings. PLOS Negl Trop Dis. 2020 Feb 24; 14(2): e0007466.

  15. Kabir T, Anwar S, Taslem Mourosi J, Hossain J, et al. Arsenic hampered embryonic development: an in vivo study using local Bangladeshi Danio rerio model. Toxicol Rep. 2020 Jan 11; 7: 155–61.

  16. Miah MF, Anwar S, Ali MH, Naser MN, Ahmed K. Assessment of genetic diversity of freshwater mud eel (Monopterus cuchia) using RAPD and RFLP markers. J Aquac Res Development. 2018 Sep 29; 9(7): 1000543.

  17. Ali MH, Anwar S, Roy PK, Ashrafuzzaman M. Virtual screening for identification of small lead compound inhibitors of Nipah virus attachment glycoprotein. J Pharmacogenomics Pharmacoproteomics. 2018 Sep 4; 9(2): 1000180.

Review articles

¹Co-first authors

²corresponding authors

  1. Anwar S, Yokota T. The Dysferlinopathies conundrum: Clinical spectra, disease mechanism and genetic approaches for treatments. Biomolecules. 2024 Feb 21; 14(3): 256.

  2. Anwar S, Yokota T. Navigating the complex landscape of fibrodysplasia ossificans progressiva: from current paradigms to therapeutic frontiers. Genes. 2023 Nov 30;14(12): 2162.

  3. Anwar S, Mir F, Yokota T. Enhancing the effectiveness of oligonucleotide therapeutics using cell-penetrating peptide conjugation, chemical modification, and carrier-based delivery strategies. Pharmaceutics. 2023 Apr 3; 15(4): 1130.

  4. Tabassum T, Farzana M, Nahar AN, Araf Y, et al. COVID-19 in Bangladesh: wave-centric assessments and mitigation measures for future pandemics. Heliyon. 2023 Oct 1;9(10): e20113.

  5. Mourosi JT, Anwar S, Hosen MJ. The sex and gender dimensions of COVID-19: A narrative review of the potential underlying factors. Infect Genet Evol. 2022 Sep 1; 103: 105338.

  6. Akter F, Araf Y, Anwar S, Hosen MJ, Zheng C. Constructing human genetic disease database in Bangladesh. GPD. 2022 Jun 29; 1(1): 78.

  7. Hosen MJ, Anwar S, Taslem Mourosi J, Chakraborty S, Miah MF, Vanakker OM. Genetic counseling in the context of Bangladesh: current scenario, challenges, and a framework for genetic service implementation. Orphanet J Rare Dis. 2021 Dec;16(1): 1–5.

  8. Chowdhury SF, Sium SM, Anwar S². Research and management of rare diseases in the COVID-19 pandemic era: challenges and countermeasures. Front Public Health. 2021 Apr 15;9: 640282.

  9. Araf Y, Faruqui NA, Anwar S, Hosen MJ. SARS-CoV-2: a new dimension to our understanding of coronaviruses. Int Microbiol. 2021 Jan; 24: 19–24.

  10. Anwar S, Yokota T. Golodirsen for Duchenne muscular dystrophy. Drugs Today. 2020 Aug 01;56(8): 491–504.

  11. Chowdhury SF, Anwar S². Management of hemoglobin disorders during the COVID-19 pandemic. Front Med. 2020 Jun 9;7: 306.

  12. Anwar S, Nasrullah M, Hosen MJ. COVID-19 and Bangladesh: challenges and how to address them. Front Public Health. 2020 Apr 30;8: 154.

Book chapters

¹Co-first authors

²corresponding authors

  1. Anwar S, Yokota T. Progress and future directions in exon skipping and inclusion therapies: the landscape of oligonucleotide-based genetic medicine. In: Echigoya Y, Maruyama R, and Yokota T. (eds) Exon Skipping and Inclusion Therapies, 2nd Edition. Methods Mol Biol. New York, NY: Springer US. [Accepted, in press]

  2. H Sarah¹, Anwar S¹, Yokota T. Alkaline phosphatase detection and alizarin red S staining in fibrodysplasia ossificans progressiva patient-derived fibroblasts and C2C12 myoblasts transfected with ACVR1ᴿ²⁰⁶ᴴ plasmids. In: Asakura A (ed) Imaging Analysis of Muscle Stem Cells and Regeneration. Methods Mol Biol. New York, NY: Springer US. [Accepted, in press]

  3. Anwar S, Yokota T. Rapid freezing of skeletal and cardiac muscles using isopentane cooled with liquid nitrogen and tragacanth gum for histological, genetic, and protein expression studies. In: Maruyama R, Yokota T. (eds) Muscular Dystrophy Therapeutics. Methods Mol Biol. 2022 Nov 19; 2587: 45–53. New York, NY: Springer US.

  4. Anwar S, Yokota T. Morpholino-mediated exons 28–29 skipping of dysferlin and characterization of multiexon-skipped dysferlin using RT-PCR, immunoblotting, and membrane wounding assay. In: Maruyama R, Yokota T. (eds) Muscular Dystrophy Therapeutics. Methods Mol Biol. 2022 Nov 19; 2587: 183–196. New York, NY: Springer US.

Select presentations

Oral Presentations​

  1. Anwar S, Maruyama R, Yokota T. Antisense oligonucleotide-mediated exon 27 skipping of dysferlin for the treatment of dysferlinopathy. WCHRI Research Day 2021, University of Alberta, Edmonton, AB, Canada. 2021 Nov 3–4. [Best Presenter Award—PhD category]

  2. Anwar S, Taslem Mourosi J, Khan MF, Ullah MO, Vanakker O, Hosen MJ. Chikungunya Outbreak in Bangladesh (2017): clinical and hematological findings. Int’l Conference on Advancement of Life Sciences 2019, Mawlana Bhashani Science & Technology University, Tangail, Bangladesh. 2019 Apr 5–6.

  3. Anwar S, Miah MF. Detection of α-thalassemia by screening umbilical cord blood in Bangladesh. Int’l Conference on Biological and Environmental Research, Jessore University of Science & Technology, Jashore, Bangladesh. 2018 Sep 16–17.

 

Poster Presentations

  1. Anwar S, B Scott, Tang A, Maruyama R, Moulton HM, Yokota T. Enhancing antisense oligonucleotide efficacy with small molecule oligonucleotide activity enhancers. Mol Ther. 2024 April 22; 32(4S1): 364–65. In Abstracts: American Society of Gene & Cell Therapy 27th Annual Meeting, Baltimore, MD, USA. 2024 May 7–11. [Outstanding Poster Award]

  2. Anwar S, Maruyama R, Yokota T. Antisense oligonucleotide-mediated exon 27 skipping restores dysferlin expression and function in dysferlinopathy patient-derived cells. WCHRI Research Day 2023, University of Alberta, Edmonton, AB, Canada. 2023 Oct 18.

  3. Anwar S, Maruyama R, Yokota T. Targeted exon 27 skipping via antisense oligonucleotides restores dysferlin expression and function in dysferlinopathy patient-derived cells. Medical Genetics Research Day 2022, University of Alberta, Edmonton, AB, Canada. 2023 Sep 13.

  4. Anwar S, Maruyama R, Witzigmann D, Chan KYT, Cullis PR, Yokota T. Nucleoside modification and lipid nanoparticle-mediated delivery enhances the efficacy and safety of gapmer antisense oligonucleotides for the treatment of facioscapulohumeral muscular dystrophy. WCHRI Research Day 2022, University of Alberta, Edmonton, AB, Canada. 2022 Nov 2–3.

  5. Anwar S, Maruyama R, Witzigmann D, Chan KYT, Cullis PR, Yokota T. Lipid nanoparticle-mediated delivery and nucleoside modification enhances the efficacy and safety of gapmer antisense oligonucleotides for the treatment of facioscapulohumeral muscular dystrophy. Medical Genetics Research Day 2022, University of Alberta, Edmonton, AB, Canada. 2022 Oct 19. [Best Poster Award—PhD/Postdoc Category]

  6. Anwar S, Maruyama R, Yokota T. Antisense oligonucleotide-mediated exon 27 skipping of dysferlin for the treatment of dysferlinopathy. Mol Ther. 2022 May 02; 30(4S1): 277–78. In Abstracts: American Society of Gene & Cell Therapy 25th Annual Meeting, Washington, DC, USA. 2022 May 16–19.

  7. Anwar S, He M, Lim KRQ, Maruyama R, Yokota T. A genotype-phenotype correlation study of exon skip-equivalent in-frame deletions across dystrophin to identify promising targets for exon-skipping therapies for Duchenne muscular dystrophy: a meta-analysis. Medical Genetics Research Day 2020, University of Alberta, Edmonton, AB, Canada. 2020 Nov 18.

  8. Taslem Mourosi J, Anwar S, Hosen MJ. Socio-demographic and hemato-biochemical characterization and the role of intronic variants in GRIN2B gene in Autism. World DNA Day Conference, Rajshahi University, Rajshahi, Bangladesh. 2019 May 2–3. [Best Poster Award]

  9. Sharmin S, Saurav AHM, Dey P, Deb A, Anwar S, Roy T, Vanakker OM, Hosen MJ. Elucidation of the molecular mechanism of two Bangladeshi patients with Hutchinson-Gilford Progeria Syndrome. International Conference on Advancement of Life Sciences 2019, Mawlana Bhashani Science & Technology University, Tangail, Bangladesh. 2019 Apr 5–6. [Best Poster Award]

  10. Anwar S, Miah MF. Detection of α-thalassemia by screening umbilical cord blood in Bangladesh. Blood Res. 2019 Mar 01; 54(S1): 327. In Abstracts: 2019 Korean Society of Hematology International Conference & 60th Annual Meeting, Seoul, Korea. 2019 March 14–16.

  11. Anwar S, Taslem Mourosi J, Chhoya SH, Hosen MJ. Abnormal serum lipid levels and relative risk for hypothyroidism in patients with diabetes mellitus in Bangladeshi population. International Conference on Biological and Environmental Research, Jessore University of Science & Technology, Jashore, Bangladesh. 2018 Sep 16–17. [Best Poster Award]

  12. Tabassum E, Nawaar N, Bhuiyan MFH, Anwar S, Hosen MJ. Identification of potential therapeutic targets in Proteus mirabilis: a subtractive genomics approach. 31st Annual Conference of Bangladesh Society of Microbiologists, Dhaka, Bangladesh.  2017 Dec 29–30. [Best Poster Award]

bottom of page